Hypoglycemia
Dangerously low blood sugar — mainly a risk when GLP-1 drugs combine with insulin or sulfonylureas.
GLP-1 medications alone rarely cause hypoglycemia; their insulin effect is glucose-dependent, switching off as sugar normalizes. The risk ignites in combination: patients taking insulin or sulfonylureas (older diabetes drugs that force insulin release) can find those doses suddenly oversized as GLP-1 therapy and weight loss improve glucose control.
Symptoms — shakiness, sweating, racing heart, confusion, irritability — demand fast carbohydrate, then a medication review. The structural fix is coordination: diabetic patients starting weight therapy should have their diabetes regimen actively co-managed, often with preemptive dose reductions. Non-diabetic patients experiencing lightheadedness are usually meeting dehydration or under-eating, not true hypoglycemia, but persistent episodes merit checking.
This glossary entry is general information, not medical advice, and is written to be consistent with FDA prescribing information and primary trial publications as of its last review. Always consult a licensed healthcare provider for personal medical decisions.
Questions about Hypoglycemia? Ask a doctor free.
A licensed doctor can apply this to your health history in a free telehealth consultation — booking takes about two minutes, with programs from $149/month. You're only charged after approval.
Book an Appointment